Not applicableStudy completedNCT02828917What this trial is testingMedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)Who this might be right forde Novo or Restenosis Lesions Medinol Ltd. 104
Post-approval studies (Phase 4)Study completedNCT00332397What this trial is testingThe Efficacy of Three Different Limus Agent-Eluting Stents to Prevent RestenosisWho this might be right forCoronary Disease Deutsches Herzzentrum Muenchen 1,007
Not applicableEnrolling By InvitationNCT07159087What this trial is testingThe Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISRWho this might be right forCoronary Arterial Disease (CAD) Genoss Co., Ltd. 94
Post-approval studies (Phase 4)Study completedNCT00497172What this trial is testingDiabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialWho this might be right forCoronary Artery Disease Cordis US Corp. 150
Post-approval studies (Phase 4)UnknownNCT05623995What this trial is testingEffect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)Who this might be right forIn-stent RestenosisMajor Adverse Cardiovascular Events Lin Zhao 200
Not applicableStudy completedNCT04862052What this trial is testingOptimal Treatment for Coronary Drug Eluting Stent In-stent RestenosisWho this might be right forCoronary Stent Restenosis Semmelweis University Heart and Vascular Center 108
Not applicableUnknownNCT00226525What this trial is testingEffect of Metal Skin Sensitivity on Restenosis After Stent ImplantationWho this might be right forCoronary Stent Restenosis Hadassah Medical Organization 150
Not applicableEnded earlyNCT02528474What this trial is testingComparison of Optical Coherence Tomographic Findings After Balloon Angioplasty With Two Different Paclitaxel-Coated Balloons for the Treatment of In-Stent Restenosis in Drug-Eluting StentsWho this might be right forCoronary Artery Disease Yonsei University 24
Post-approval studies (Phase 4)Study completedNCT00627900What this trial is testingCost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting StentsWho this might be right forCoronary Artery Disease Charite University, Berlin, Germany 958
Not applicableStudy completedNCT05089864What this trial is testingSTAR and Deferred Stenting StudyWho this might be right forCoronary OcclusionCoronary StenosisCoronary Restenosis Saint Luke's Health System 150
Testing effectiveness (Phase 2)Study completedNCT01140204What this trial is testingShort-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast MediaWho this might be right forCoronary Artery Disease University Hospital, Saarland 32
Not applicableLooking for participantsNCT06845410What this trial is testingClinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort StudyWho this might be right forCoronary Artery DiseaseCoronary Artery Disease ProgressionCoronary Artery Stenosis+4 more Peking Union Medical College Hospital 120
Not applicableStudy completedNCT05471245What this trial is testingAnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery DiseaseWho this might be right forCoronary Restenosis Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS 110
Post-approval studies (Phase 4)Study completedNCT01171820What this trial is testingSPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)Who this might be right forCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis Abbott Medical Devices 324
Testing effectiveness (Phase 2)Study completedNCT00124943What this trial is testingUse of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent RestenosisWho this might be right forCoronary Restenosis Celgene Corporation 112
Large-scale testing (Phase 3)Study completedNCT00055510What this trial is testingA Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.Who this might be right forGraft Occlusion, VascularCoronary RestenosisAtherosclerosis Chugai Pharma USA
Large-scale testing (Phase 3)Ended earlyNCT00538759What this trial is testingRadiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent RestenosisWho this might be right forAortic Valve Stenosis Minneapolis Heart Institute Foundation 21
Not applicableNot Yet RecruitingNCT07382154What this trial is testingTarget Vessel Failure After Laser Assisted Percutaneous Angioplasty Versus Balloon-based Treatment for Drug Eluting In-stent RestenosisWho this might be right forIn-stent Restenosis IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,260
Not applicableEnded earlyNCT00777842What this trial is testingEvaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary ArteryWho this might be right forCoronary Artery Disease Cook Group Incorporated 19
Not applicableNot Yet RecruitingNCT07391033What this trial is testingThe PICCOLETO XI A-PREP StudyWho this might be right forIn-Stent Coronary Artery RestenosisCoronary Artery Disease Fondazione Ricerca e Innovazione Cardiovascolare ETS 500